All Stories

  1. Patient-Reported Financial Toxicity of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Article • Annals of Surgical Oncology, March 2026, Springer Science + Business Media

    Luis Felipe Falla Zuniga

  2. Clinical Characteristics and Outcomes of Patients with Goblet Cell Adenocarcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Multicenter Cohort Study

    Article • European Journal of Surgical Oncology, February 2026, Elsevier

    Luis Felipe Falla Zuniga

  3. Controlling Perfusion Temperature Relates to Better Outcomes after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Article • European Journal of Surgical Oncology, October 2025, Elsevier

    Luis Felipe Falla Zuniga, Dr. Andrei Nikiforchin

  4. Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer

    Article • Annals of Surgical Oncology, September 2025, Springer Science + Business Media

    Luis Felipe Falla Zuniga

  5. Small bowel obstruction and ovarian cancer: insights from a propensity-score matched study in patients with and without hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

    Article • World Journal of Surgical Oncology, August 2025, Springer Science + Business Media

    Luis Felipe Falla Zuniga

  6. The Effect of Prior Nondefinitive Surgery on Perioperative Outcomes and Survival in Mucinous Appendix Cancer Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    Article • The American Surgeon, June 2025, SAGE Publications

    Luis Felipe Falla Zuniga

  7. Presentation Patterns and Treatment Outcomes in Appendix Cancer Patients Traveling to a High-Volume Peritoneal Surface Malignancy Center

    Article • The American Surgeon, May 2025, SAGE Publications

    Luis Felipe Falla Zuniga

  8. Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    Article • Gynecologic Oncology Reports, April 2025, Elsevier

    Luis Felipe Falla Zuniga

  9. Prognostic Value of Preoperative Serum C-reactive Protein Level for Survival in Mucinous Appendix Cancer Treated with Complete CRS/HIPEC

    Article • European Journal of Surgical Oncology, February 2025, Elsevier

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  10. Reply to: Questioning the role of HIPEC in patients with granulosa cell ovarian tumours

    Article • Pleura and Peritoneum, December 2024, De Gruyter

    Luis Felipe Falla Zuniga

  11. Surgical management of peritoneal metastases from appendix and colon cancer in patients with inflammatory bowel disease

    Article • Surgical Oncology Insight, December 2024, Elsevier

    Luis Felipe Falla Zuniga

  12. Systemic inflammatory markers: Predictors of survival in mucinous appendix cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

    Article • Surgical Oncology Insight, December 2024, Elsevier

    Luis Felipe Falla Zuniga

  13. ASO Visual Abstract: Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through in-Depth Interviews

    Article • Annals of Surgical Oncology, November 2024, Springer Science + Business Media

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  14. ASO Author Reflections: Qualitative Research as an Avenue for Evaluating Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

    Article • Annals of Surgical Oncology, July 2024, Springer Science + Business Media

    Luis Felipe Falla Zuniga

  15. Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through In-Depth Interviews

    Article • Annals of Surgical Oncology, July 2024, Springer Science + Business Media

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  16. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) vs. Postoperative Intraperitoneal (IP) Chemotherapy - Impact on Health-Related Quality of Life in Primary Ovarian Cancer Patients after Cytoreductive Surgery

    Article • Surgical Oncology Insight, July 2024, Elsevier

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  17. ASO Visual Abstract: Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix

    Article • Annals of Surgical Oncology, January 2024, Springer Science + Business Media

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  18. Collaborative expertise of gynecological and surgical oncologists in managing advanced epithelial ovarian cancer

    Article • European Journal of Surgical Oncology, January 2024, Elsevier

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  19. Sufficient Regional Lymph Node Examination for Staging Adenocarcinoma of the Appendix

    Article • Annals of Surgical Oncology, December 2023, Springer Science + Business Media

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  20. Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

    Article • Pleura and Peritoneum, December 2023, De Gruyter

    Luis Felipe Falla Zuniga

  21. Patterns of Recurrence in Appendix Cancer After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy

    Article • Annals of Surgical Oncology, August 2023, Springer Science + Business Media

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  22. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma

    Article • European Journal of Surgical Oncology, March 2023, Elsevier

    Dr. Andrei Nikiforchin, Luis Felipe Falla Zuniga

  23. Thyroid hormones: Metabolism and transportation in the fetoplacental unit

    Article • Molecular Reproduction and Development, October 2022, Wiley

    Luis Felipe Falla Zuniga

  24. Tratamiento de la eclampsia y miastenia gravis: reporte de un caso y revisión de la literatura

    Article • Revista chilena de obstetricia y ginecología, January 2022, Publicidad Permanyer, SLU

    Luis Felipe Falla Zuniga

  25. Anisákidos y anisakidosis: Reportes de caso y hospedadores en América del Sur. Revisión sistemática.

    Article • Revista de la Facultad de Medicina, April 2021, Universidad Nacional de Colombia

    Luis Felipe Falla Zuniga

  26. Mus musculus: biomodelo de expresión de Desyodinasa (DIO3) y Transtiretina (TTR) en el desarrollo placentario

    Article • ENTRAMADO, January 2021, Universidad Libre Seccional Cali

    Luis Felipe Falla Zuniga

  27. Structural remodelling of the heart valves extracellular matrix during embryo development

    Article • Anatomia Histologia Embryologia, August 2020, Wiley

    Luis Felipe Falla Zuniga

  28. Anisákidos y anisakidosis: generalidades y su actualidad en Colombia. Revisión bibliográfica

    Article • IATREIA, April 2020, Universidad de Antioquia

    Luis Felipe Falla Zuniga